title: [Efficiency of combination therapy for acute otitis media].
abstract: The clinical efficiency of treatment was evaluated in 60 patients aged 18 to 60 years with protracted acute otitis media (AOM) who had residual tympanic membrane inflammation and exudates in the tympanic cavity. The patients were divided into 2 groups of 30 each, who received equal basic medical treatment; Group 1 patients were additionally given eurespal (fenspiride) 80 mg thrice daily for 2 weeks. The patients were examined by clinical, endoscopic, and audiometric studies; the transport function of the nasal ciliated epithelium was also explored. The findings suggest the benefits of the additional use of eurespal in the treatment of the catarrhal stage of AOM.
authors.forename: S D
authors.initials: SD
authors.lastname: Poliakova
authors.forename: E A
authors.initials: EA
authors.lastname: Nekrasova
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D005122:Exudates and Transudates; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy* / Q000473:pathology*; D013141:Spiro Compounds / Q000627:therapeutic use*; D014432:Tympanic Membrane / Q000473:pathology*; D055815:Young Adult
chemical_list: D013141:Spiro Compounds; C084775:fenspiride